The Harvard Apparatus ECM 2001+, Hybridoma Production System is a high-performance electroporation device designed for hybridoma cell fusion and monoclonal antibody production. It features precise control over electroporation parameters and includes coaxial chambers with identical electrical properties, enabling seamless scale-up from optimisation to production. A transparent-bottom optimisation chamber allows visual monitoring of cell alignment under an inverted or standard microscope, making it ideal for immunology and biotechnology applications.
Scope of Supply:
This system is an essential solution for laboratories focused on efficient monoclonal antibody development and high-yield hybridoma production.
It is a high-performance electroporation device designed for hybridoma cell fusion and monoclonal antibody production. It features precise control over electroporation parameters and includes coaxial chambers with identical electrical properties, enabling seamless scale-up from optimisation to production. A transparent-bottom optimisation chamber allows visual monitoring of cell alignment under an inverted or standard microscope, making it ideal for immunology and biotechnology applications.
Yes. It is designed for hybridoma generation and monoclonal antibody production, and offers accurate pulse control for optimal cell fusion and reliable and reproducible results for immunology and biotechnology applications to support this kind of work.
It has accurate pulse control for optimal cell fusion, reliable and reproducible results for immunology and biotechnology applications and coaxial chambers with identical electrical properties for direct scale-up.
It offers transparent-bottom optimisation chamber enables visual monitoring of cell alignment, ECM® 2001+ Generator, coaxial optimisation chamber (2 ml) and coaxial production chamber (9 ml).
Just add items to your shopping cart and select “Instant Quote”